These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 19251184

  • 1. Discharge medications among ischemic stroke survivors.
    Sweileh WM, Sawalha AF, Zyoud SH, Al-Jabi SW, Abaas MA.
    J Stroke Cerebrovasc Dis; 2009; 18(2):97-102. PubMed ID: 19251184
    [Abstract] [Full Text] [Related]

  • 2. High prevalence of previous antiplatelet drug use in patients with new or recurrent ischemic stroke: Buffalo metropolitan area and Erie County stroke study.
    Qureshi AI, Kirmani JF, Safdar A, Ahmed S, Sayed MA, Pande RU, Ferguson R, Hershey LA, Qazi KJ.
    Pharmacotherapy; 2006 Apr; 26(4):493-8. PubMed ID: 16553507
    [Abstract] [Full Text] [Related]

  • 3. Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors.
    Burke JP, Sander S, Shah H, Zarotsky V, Henk H.
    Curr Med Res Opin; 2010 May; 26(5):1023-30. PubMed ID: 20199138
    [Abstract] [Full Text] [Related]

  • 4. One-year follow-up healthcare costs of patients hospitalized for transient ischemic attack or ischemic stroke and discharged with aspirin plus extended-release dipyridamole or clopidogrel.
    Burton TM, Lacey M, Liu F, Yu Y, Monsalvo ML, Lang K, Sander S.
    J Med Econ; 2012 May; 15(6):1217-25. PubMed ID: 22857539
    [Abstract] [Full Text] [Related]

  • 5. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A, Dzialowski I, Koch R, Gahn G.
    J Neurol Sci; 2009 Sep 15; 284(1-2):155-7. PubMed ID: 19473668
    [Abstract] [Full Text] [Related]

  • 6. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J.
    J Neurol Sci; 2009 Sep 15; 284(1-2):1-9. PubMed ID: 19380153
    [Abstract] [Full Text] [Related]

  • 7. Safety and tolerability of 600 mg clopidogrel bolus in patients with acute ischemic stroke: preliminary experience.
    Suri MF, Hussein HM, Abdelmoula MM, Divani AA, Qureshi AI.
    Med Sci Monit; 2008 Oct 15; 14(10):PI39-44. PubMed ID: 18830204
    [Abstract] [Full Text] [Related]

  • 8. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
    Sztriha LK, Vécsei L.
    Ideggyogy Sz; 2008 May 30; 61(5-6):148-54. PubMed ID: 18567389
    [Abstract] [Full Text] [Related]

  • 9. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP, Saseen JJ.
    Pharmacotherapy; 2008 Oct 30; 28(10):1233-42. PubMed ID: 18823219
    [Abstract] [Full Text] [Related]

  • 10. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC.
    Int J Stroke; 2006 Feb 30; 1(1):4-8. PubMed ID: 18706062
    [Abstract] [Full Text] [Related]

  • 11. Antiplatelet drugs for ischemic stroke prevention.
    Leys D, Balucani C, Cordonnier C.
    Cerebrovasc Dis; 2009 Feb 30; 27 Suppl 1():120-5. PubMed ID: 19342841
    [Abstract] [Full Text] [Related]

  • 12. Platelet aggregation and recruitment with aspirin-clopidogrel therapy.
    Helgason CM, Grossi E, Pandey D, Valika A, Cursio J, Brace LD.
    Cerebrovasc Dis; 2008 Feb 30; 25(5):392-400. PubMed ID: 18349532
    [Abstract] [Full Text] [Related]

  • 13. Comparison between aspirin combined with dipyridamole versus aspirin alone within 48 hours after ischemic stroke event for prevention of recurrent stroke and improvement of neurological function: a preliminary study.
    Chairangsarit P, Sithinamsuwan P, Niyasom S, Udommongkol C, Nidhinandana S, Suwantamee J.
    J Med Assoc Thai; 2005 Nov 30; 88 Suppl 3():S148-54. PubMed ID: 16858953
    [Abstract] [Full Text] [Related]

  • 14. Role of antiplatelet therapy in cardiovascular disease II: Ischemic stroke.
    Cavendish JJ, Cramer SC, Graham GD.
    Curr Med Res Opin; 2004 Nov 30; 20(11):1845-9. PubMed ID: 15537485
    [Abstract] [Full Text] [Related]

  • 15. Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic stroke.
    Karepov V, Tolpina G, Kuliczkowski W, Serebruany V.
    Cerebrovasc Dis; 2008 Nov 30; 26(3):272-6. PubMed ID: 18648200
    [Abstract] [Full Text] [Related]

  • 16. Pretreatment with aspirin and etiology of first-ever ischemic stroke in young and middle-aged patients.
    Telman G, Kouperberg E, Sprecher E, Yarnitsky D.
    J Neurol Sci; 2009 Jun 15; 281(1-2):2-5. PubMed ID: 19351569
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events.
    Gengo FM, Rainka M, Robson M, Gengo MF, Forrest A, Hourihane M, Bates V.
    J Clin Pharmacol; 2008 Mar 15; 48(3):335-43. PubMed ID: 18223144
    [Abstract] [Full Text] [Related]

  • 18. Antiplatelet agents for prevention of recurrent ischemic stroke.
    Hegge KA.
    S D Med; 2009 Jan 15; 62(1):15-7. PubMed ID: 19245087
    [Abstract] [Full Text] [Related]

  • 19. An approach of patients with ischemic stroke to primary and secondary stroke prevention in Poland.
    Nowacki P, Porebska A, Bajer-Czajkowska A, Zywica A, Koziarska D, Podbielski J.
    Ann Acad Med Stetin; 2007 Jan 15; 53(2):14-9. PubMed ID: 18557372
    [Abstract] [Full Text] [Related]

  • 20. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage.
    Toyoda K, Okada Y, Minematsu K, Kamouchi M, Fujimoto S, Ibayashi S, Inoue T.
    Neurology; 2005 Oct 11; 65(7):1000-4. PubMed ID: 16217049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.